| Literature DB >> 26613880 |
Antonio Luna1, Shivani Pahwa2, Claudio Bonini3, Lidia Alcalá-Mata4, Katherine L Wright2, Vikas Gulani5.
Abstract
Modern MR imaging protocols can yield both anatomic and functional information for the assessment of hepatobiliary and pancreatic malignancies. Diffusion-weighted imaging is fully integrated into state-of-the-art protocols for tumor detection, characterization, and therapy monitoring. Hepatobiliary contrast agents have gained ground in the evaluation of focal liver lesions during the last years. Perfusion MR imaging is expected to have a central role for monitoring therapy in body tumors treated with antivascular drugs. Approaches such as Magnetic resonance (MR) elastography and (1)H-MR spectroscopy are still confined to research centers, but with the potential to grow in a short time frame.Entities:
Keywords: (1)H-MR spectroscopy; Biomarker; DWI; Hepatobiliary contrast agents; MR elastography; MR imaging; Multiparametric; Perfusion MR imaging
Mesh:
Substances:
Year: 2016 PMID: 26613880 PMCID: PMC4974463 DOI: 10.1016/j.mric.2015.08.005
Source DB: PubMed Journal: Magn Reson Imaging Clin N Am ISSN: 1064-9689 Impact factor: 2.266